A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations
Clinical trial NCT06362980 · UNKNOWN
Trial details
- NCT number
- NCT06362980
- Sponsor
- National Cancer Center, China
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-22
- Primary completion
- 2025-04-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.